VERRICA PHARMACEUTICALS INC's ticker is VRCA and the CUSIP is 92511W108. A total of 48 filers reported holding VERRICA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $91,027 | -23.1% | 23,433 | +14.2% | 0.00% | – |
| Q2 2023 | $118,388 | +13.8% | 20,518 | +60.7% | 0.00% | – |
| Q1 2022 | $104,000 | -14.8% | 12,769 | -4.3% | 0.00% | – |
| Q4 2021 | $122,000 | -24.7% | 13,348 | +2.9% | 0.00% | – |
| Q3 2021 | $162,000 | +11.7% | 12,976 | +1.0% | 0.00% | – |
| Q2 2021 | $145,000 | -28.9% | 12,844 | -4.4% | 0.00% | – |
| Q1 2021 | $204,000 | +25.9% | 13,434 | -4.7% | 0.00% | – |
| Q4 2020 | $162,000 | +58.8% | 14,094 | +6.9% | 0.00% | – |
| Q3 2020 | $102,000 | -39.6% | 13,184 | -14.0% | 0.00% | – |
| Q2 2020 | $169,000 | -10.6% | 15,324 | -11.6% | 0.00% | – |
| Q1 2020 | $189,000 | -31.0% | 17,327 | +0.6% | 0.00% | – |
| Q4 2019 | $274,000 | +9.6% | 17,227 | +1.8% | 0.00% | – |
| Q3 2019 | $250,000 | +34.4% | 16,918 | +5.6% | 0.00% | – |
| Q2 2019 | $186,000 | +67.6% | 16,020 | +56.3% | 0.00% | – |
| Q1 2019 | $111,000 | – | 10,250 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 5,038,983 | $19,576,448 | 0.65% |
| BML Capital Management, LLC | 150,000 | $582,750 | 0.54% |
| Caligan Partners LP | 259,593 | $1,009,817 | 0.46% |
| Avoro Capital Advisors LLC | 2,954,064 | $11,476,539 | 0.18% |
| Boxer Capital, LLC | 166,955 | $648,620 | 0.04% |
| SteelPeak Wealth, LLC | 136,986 | $532,191 | 0.03% |
| Legacy Trust | 18,750 | $72,844 | 0.02% |
| Miracle Mile Advisors, LLC | 118,221 | $459,289 | 0.01% |
| SPC Financial, Inc. | 30,000 | $116,550 | 0.01% |
| KORNITZER CAPITAL MANAGEMENT INC /KS | 99,251 | $385,590 | 0.01% |